Medingo was established in the heart of the Silicon Valley of Israel in 2005 to develop medical devices to improve the quality of life for people living with diabetes.  Medingo is owned by a large technology firm Elron (NASDAQ: ELRN) a firm that has backed many breakthrough technologies including the first CT Scan (later acquired by GE Healthcare), and the PillCam® for gastrointestinal studies (Given Imaging).
 
Medingo’s founder, Ofer Yodfat, MD, has an extensive knowledge of diabetes and funded thousands of hours of customer and healthcare professional interviews, focus groups and usability studies during the design of Solo to ensure it met your needs and expectations.

For more infomation about Medingo - www.medingo.com